Publications: Mejzini, Rita

Journal Article

Foster, A.D., Flynn, L.L., Cluning, C., Cheng, F., Davidson, J.M., Lee, A., Polain, N., Mejzini, R., Farrawell, N., Yerbury, J.J., Layfield, R., Akkari, P.A. and Rea, S.L. (2021) p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death. Scientific Reports, 11 (1). Art. 11474.

Mejzini, R., Flynn, L.L., Pitout, I.L., Fletcher, S., Wilton, S.D. and Akkari, P.A. (2019) ALS genetics, mechanisms, and therapeutics: Where are we now? Frontiers in Neuroscience, 13 .

Thesis

Mejzini, Rita (2022) Development of antisense oligonucleotides with therapeutic potential for treating amyotrophic lateral sclerosis. PhD thesis, Murdoch University.

Mejzini, Rita (2016) Novel strategy to inhibit the oncogenic transcription factor c-Myc in triple-negative breast cancer. Honours thesis, Murdoch University.